The University of Texas MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2025

The University of Texas MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2025

 Information:

The course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.

1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.
2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
3. Demonstrate proficiency of knowledge in hematology and medical oncology.
4. Incorporate recent advances in management of hematologic and oncologic patients.

Official course reference: MD Anderson lists the 2025 comprehensive review as a six-day virtual program held September 15–20 for hematology and medical oncology certification and recertification preparation. This store purchase provides downloadable course files only; MD Anderson platform access, CME credit and certificates are not included.